Navigation Links
OHK Medical Devices Selects Henry Schein as Exclusive Distributor of HemaClear®
Date:2/16/2011

NEWARK, N.J., Feb. 16, 2011 /PRNewswire/ -- OHK Medical Devices, Inc. announced today that it has selected Henry Schein Medical, the U.S. physician business of Henry Schein Inc. (Nasdaq: HSIC), the largest distributor of health care products and services to office-based dental, medical and veterinary practitioners, as the exclusive distributor of HemaClear® for the U.S. alternate care market. HemaClear is the first and only surgical tourniquet single-use device that exsanguinates, occludes, and provides a clearer surgical field.

"HemaClear is delighted to be partnering with a company that has such an excellent reputation for bringing its customers the highest quality and most innovative products on the market," said Oren Gavriely, Chief Executive Officer, OHK Medical Devices.  "We are very much looking forward to bringing this new, revolutionary standard of care to Henry Schein customers around the country."

An exsanguination device that prepares any limb for surgery in less than 12 seconds, HemaClear provides a larger, dryer, and clearer surgical field, thereby providing the surgeon with a better view of anatomical structures. Its ease of use and simplicity saves valuable operating room time.  HemaClear has been proven worldwide in over 180,000 surgical cases.

"Henry Schein Medical is pleased to exclusively offer HemaClear as part of our ongoing commitment to help drive the success of our customers' practices and enable them to provide the highest quality care," said Dave McKinley, President of Henry Schein Medical.  "This innovative new technology is simple, sterile, safe, cost-effective, and ultimately provides more successful surgical outcomes, especially for our customers that practice in ambulatory surgical settings and perform office-based procedures."

About HemaClear

Manufactured by OHK Medical Devices, Inc., headquartered in Haifa, Israel, HemaClear® is the first self-contained, sterile, exsanguinating tourniquet that creates a bloodless field in seconds. HemaClear® performs three functions: blood removal (exsanguination), arterial flow occlusion, and automatic application of the sterile stockinet. HemaClear® replaces traditional devices, completely eliminating the need for a tourniquet machine, tourniquet cuff, Esmarch bandage, Webril™ and stockinet.

Perhaps most advantageous of all, from a logistics point of view, HemaClear® is self-contained and requires absolutely no connections or power source.  HemaClear's innovative technology not only reduces blood loss, infection, and the volume of ischemic tissue, its simplicity saves precious operating room set-up time‚ as much as fifteen minutes‚ and over 10 separate steps and products that can save as much as $300 a procedure.

Hemaclear is used as a standard of care in over 25 countries and over 180,000 of Hemaclear's tourniquets have been applied. For more information, visit the HemaClear site at www.Hemaclear.com, or visit http://www.youtube.com/watch?v=L46SI03Lpl0

About Henry Schein

Henry Schein, Inc. (Nasdaq: HSIC), the largest provider of health care products and services to office-based practitioners, is a Fortune 500® company and a member of the NASDAQ 100® Index.  The Company is recognized for its excellent customer service and highly competitive prices.  Henry Schein's five businesses – North American Dental, North American Medical, North American Animal Health, International and Technology – serve more than 700,000 customers worldwide, including dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions.  The Company operates through a centralized and automated distribution network, which provides customers in more than 200 countries with a comprehensive selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than 100,000 additional products available as special-order items.  Henry Schein also provides exclusive, innovative technology offerings for dental, medical and veterinary professionals, including value-added practice management software and electronic health record solutions.

Headquartered in Melville, N.Y., Henry Schein employs more than 14,000 people and has operations or affiliates in 24 countries.  The Company's net sales reached a record $6.5 billion in 2009.  For more information, visit the Henry Schein Web site at www.henryschein.com.


'/>"/>
SOURCE OHK Medical Devices, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kips Bay Medical Announces Closing of its $16.5 Million Initial Public Offering of Common Stock
2. New Mexico Software Initiates Medical Second Opinion Service via Telemedicine for Remote Consultation Review
3. Mobile MIM, First FDA-Cleared Diagnostic Medical Imaging App, Now Available on the U.S. App Store
4. Cayenne Medical, Inc. Launches AperFix® II
5. Concord Medical Services Holdings to Present at Two Upcoming Conferences
6. Nfocus Neuromedical, Inc. Luna™ Aneurysm Embolization System Receives CE Mark
7. FDA Seeks to Invest in Foodborne Illness Prevention, Medical Product Safety and Countermeasures
8. FDA Finalizes Regulation For Certain Software, Hardware Used With Medical Devices
9. Medical Devices and Diagnostics Analyst Joins MLV to Further Expand its Coverage of the Life Sciences Sector
10. Varian Medical Systems Board of Directors Authorizes Repurchase of Additional 12 Million Shares of Stock Through Fiscal Year 2012; Additional Accelerated Share Repurchase Program
11. Proventix Helps Princeton Baptist Medical Center Earn National Recognition from HIMSS/ASQ for Quality Improvement Using Information Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
Breaking Medicine News(10 mins):